Period of time: 2013年6期
Publisher: Future Medicine
Founded in: 2005
Total resources: 43
ISSN: 1479-6678
Subject: R5 Internal Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Cardiology,volume 1,issue 6
Menu
By Schouten Olaf,Bax Jeroen J,Poldermans Don in (2005)
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.The cardiovascular safety of celecoxib
By Liew Danny,Krum Henry in (2005)
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.Carvedilol in chronic heart failure: past, present and future
By Weir Robin AP,Dargie Henry J in (2005)
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.Bivalirudin: a direct thrombin inhibitor used during percutaneous coronary intervention
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.By Decousus Hervé,Rivron-Guillot Karine,Girard Gaelle,Moulin Nathalie in (2005)
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.Cognitive functions in patients with cerebrovascular disease: potential impact of revascularization
By Mlekusch Wolfgang,Mlekusch Irene in (2005)
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.HDL therapy: the next big step in the treatment of atherosclerosis?
By Kostner Karam M,Cauza Edmund in (2005)
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.The role of adiponectin in atherosclerosis: do lipids tip the scales?
By von Eynatten Maximilian,Schneider Jochen G in (2005)
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligand
Future Cardiology,volume 1,issue 6 , Vol. 1, Iss. 6, 2005-11 , pp.